论文部分内容阅读
目的:探讨输卵管介入再通术联合药物及臭氧灌注治疗输卵管性不孕症的使用价值。方法:选取我院近年来收治的58例输卵管性不孕症患者作为研究对象,患者均采用输卵管介入再通术联合药物及臭氧灌注治疗,治疗后采用造影观察术后输卵管是否通畅情况,观察患者1年随访期内受孕及妊娠情况。结果:造影结果显示输卵管再通率为94.8%;1年随访期内显示受孕91.4%,其中分娩率为34.5%。结论:输卵管介入再通术联合药物及臭氧灌注治疗通而不畅或者阻塞引起的不孕症具有显著的临床价值,有助于提高患者受孕率,可在临床推广使用。
Objective: To investigate the value of interventional tubal recanalization combined with drugs and ozone infusion in the treatment of tubal infertility. Methods: 58 cases of tubal infertility patients admitted to our hospital in recent years were selected as the research object. All patients were treated with tubal interventional recanalization combined with drugs and ozone perfusion. After treatment, the tubal patency was observed by angiography. 1 year follow-up period of pregnancy and pregnancy. Results: The radiographic results showed that the tubal recanalization rate was 94.8%. The pregnancy rate was 91.4% at 1-year follow-up and the delivery rate was 34.5%. CONCLUSION: Tubal recanalization combined with drugs and ozonation therapy can lead to poor or obstructive infertility with significant clinical value, which can help improve the pregnancy rate of patients and can be used in clinical practice.